• 1. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

Methyl 2,6-dibromo-3-fluorobenzoate (CAS No. 1804417-05-7): A Comprehensive Overview in Modern Chemical Research

Methyl 2,6-dibromo-3-fluorobenzoate, identified by its unique chemical identifier CAS No. 1804417-05-7, is a compound of significant interest in the realm of chemical and pharmaceutical research. This molecule, characterized by its bromine and fluorine substituents on a benzoate backbone, has garnered attention due to its potential applications in various scientific domains. The structural features of Methyl 2,6-dibromo-3-fluorobenzoate make it a versatile intermediate in the synthesis of more complex molecules, particularly in the development of novel agrochemicals and pharmaceutical agents.

The benzoate core of this compound is a well-known scaffold in medicinal chemistry, often employed in the design of bioactive molecules. The presence of bromine atoms at the 2 and 6 positions enhances the electrophilicity of the aromatic ring, making it a valuable precursor for further functionalization. Similarly, the fluorine atom at the 3-position introduces electronic and steric effects that can influence the reactivity and biological activity of derivatives. These structural attributes have positioned Methyl 2,6-dibromo-3-fluorobenzoate as a key building block in synthetic chemistry.

In recent years, there has been a growing interest in fluorinated benzoates due to their role in enhancing the metabolic stability and bioavailability of drug candidates. The fluorine atom, being highly electronegative, can modulate the electronic properties of adjacent functional groups, thereby influencing both the pharmacokinetic and pharmacodynamic profiles of compounds. This has led to extensive research into the synthesis and applications of fluorinated benzoates, with Methyl 2,6-dibromo-3-fluorobenzoate being a notable example.

The bromine substituents in Methyl 2,6-dibromo-3-fluorobenzoate also contribute to its utility as a synthetic intermediate. Brominated aromatic compounds are widely used in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are fundamental to constructing complex organic molecules. The electron-withdrawing nature of bromine atoms facilitates these transformations by enhancing the reactivity of the aromatic ring towards nucleophiles. This makes Methyl 2,6-dibromo-3-fluorobenzoate a valuable reagent in multi-step synthetic routes.

One of the most compelling aspects of Methyl 2,6-dibromo-3-fluorobenzoate is its potential application in the development of novel therapeutic agents. The combination of bromine and fluorine substituents provides a rich structural framework for designing molecules with tailored biological activities. For instance, studies have shown that benzoate derivatives can exhibit antimicrobial and anti-inflammatory properties. The specific arrangement of substituents in Methyl 2,6-dibromo-3-fluorobenzoate may confer unique pharmacological effects that are yet to be fully explored.

The synthesis of Methyl 2,6-dibromo-3-fluorobenzoate involves well-established organic chemistry techniques, including halogenation and esterification reactions. These processes are typically carried out under controlled conditions to ensure high yields and purity. The ability to produce this compound efficiently is crucial for its widespread use in research and industrial applications. Recent advancements in synthetic methodologies have further improved the accessibility of such intermediates, making them more readily available for academic and commercial purposes.

The role of computational chemistry in understanding the properties of Methyl 2,6-dibromo-3-fluorobenzoate cannot be overstated. Molecular modeling techniques allow researchers to predict the behavior of this compound in various chemical environments. By simulating interactions at the molecular level, scientists can gain insights into its reactivity and potential applications. These computational studies complement experimental work by providing theoretical frameworks that guide synthetic design and mechanistic investigations.

In conclusion, Methyl 2,6-dibromo-3-fluorobenzoate (CAS No. 1804417-05-7) represents a significant advancement in chemical research due to its versatile structural features and potential applications. Its utility as a synthetic intermediate and its role in developing novel therapeutic agents underscore its importance in both academic and industrial settings. As research continues to uncover new possibilities for this compound, it is likely to remain a cornerstone of innovation in chemical biology and pharmaceutical chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)